QD 232
CAS No. 1527467-32-8
QD 232 ( QD232 )
Catalog No. M12137 CAS No. 1527467-32-8
QD 232 is a novel quinazolinedione-based redox modulator that potently inhibits Src/FAK and STAT3 phosphorylation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameQD 232
-
NoteResearch use only, not for human use.
-
Brief DescriptionQD 232 is a novel quinazolinedione-based redox modulator that potently inhibits Src/FAK and STAT3 phosphorylation.
-
DescriptionQD 232 is a novel quinazolinedione-based redox modulator that potently inhibits Src/FAK and STAT3 phosphorylation, decreasing pancreatic cancer cell viability and migration; arrests cell cycle progression and induces apoptosis at low micromolar concentrations, shows effectivity in drug-resistant cancer cell lines.
-
SynonymsQD232
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorSTAT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1527467-32-8
-
Formula Weight293.28
-
Molecular FormulaC16H11N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name6-((3-acetylphenyl)amino)quinazoline-5,8-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pathania D, et al. Br J Pharmacol. 2015 Jan;172(1):50-63.
2. Kuang Y, et al. J Med Chem. 2018 Feb 22;61(4):1576-1594.
2. Kuang Y, et al. J Med Chem. 2018 Feb 22;61(4):1576-1594.
molnova catalog
related products
-
Niclosamide
Niclosamide(BAY2353) is used for the treatment of most tapeworm infections by inhibiting DNA replication.
-
Nifuroxazide
Nifuroxazide is a cell-permeable and orally available nitrofuran-based antidiarrheal agent that effectively suppresses the activation of cellular STAT1/3/5 transcription activity .
-
HO-3867
A synthetic curcuminoid that selectively inhibits STAT3 phosphorylation, transcription, and DNA binding without affecting the expression of other active STATs.